MDxHealth is trading 5.4% higher at $0.61 in after-hours trading on October 1, 2026, versus the regular-session close of $0.58, with no clear company-specific catalyst identified.
- The move follows a mixed stretch: shares gained 12.42% on September 30 and fell 1.44% on October 1.
- MDxHealth’s 2026 press-release archive lists August 13 as its latest release, with no October 1 announcement. Broad market indices were only modestly positive, and available evidence does not establish a market-driven explanation either.